Study of the Safety and Tolerability of AXA1125 and AXA1957 in Subjects With Non-Alcoholic Fatty Liver Disease (NAFLD)

NCT04073368 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

112

Enrollment

INDUSTRY

Sponsor class

Conditions

NAFLD

Interventions

DIETARY_SUPPLEMENT: AXA1957
DIETARY_SUPPLEMENT: AXA1125
DIETARY_SUPPLEMENT: Placebo

Sponsor

Axcella Health, Inc